These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 16625606
1. Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults. Siegfried NL, Van Deventer PJ, Mahomed FA, Rutherford GW. Cochrane Database Syst Rev; 2006 Apr 19; 2006(2):CD004535. PubMed ID: 16625606 [Abstract] [Full Text] [Related]
3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. Cochrane Database Syst Rev; 2007 Jan 24; (1):CD003510. PubMed ID: 17253490 [Abstract] [Full Text] [Related]
6. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database. Zhou J, Paton NI, Ditangco R, Chen YM, Kamarulzaman A, Kumarasamy N, Lee CK, Li PC, Merati TP, Phanuphak P, Pujari S, Vibhagool A, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG. HIV Med; 2007 Jan 24; 8(1):8-16. PubMed ID: 17305926 [Abstract] [Full Text] [Related]
7. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Sturt AS, Dokubo EK, Sint TT. Cochrane Database Syst Rev; 2010 Mar 17; (3):CD008440. PubMed ID: 20238370 [Abstract] [Full Text] [Related]
10. Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study. Anekthananon T, Ratanasuwan W, Techasathit W, Sonjai A, Suwanagool S. J Med Assoc Thai; 2004 Jul 17; 87(7):760-7. PubMed ID: 15521230 [Abstract] [Full Text] [Related]
11. Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection. Yogev R, Lee S, Wiznia A, Nachman S, Stanley K, Pelton S, Mofenson L, Fiscus S, Jimenez E, Rathore MH, Smith ME, Song LY, McIntosh K, Pediatrics AIDS Clinical Trials Group 338 Study Team. Pediatr Infect Dis J; 2002 Feb 17; 21(2):119-25. PubMed ID: 11840078 [Abstract] [Full Text] [Related]
12. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals. Mbuagbaw LC, Irlam JH, Spaulding A, Rutherford GW, Siegfried N. Cochrane Database Syst Rev; 2010 Dec 08; (12):CD004246. PubMed ID: 21154355 [Abstract] [Full Text] [Related]
13. Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial). Joly V, Flandre P, Meiffredy V, Brun-Vezinet F, Gastaut JA, Goujard C, Remy G, Descamps D, Ruffault A, Certain A, Aboulker JP, Yeni P, Novavir Study Group. Antimicrob Agents Chemother; 2002 Jun 08; 46(6):1906-13. PubMed ID: 12019107 [Abstract] [Full Text] [Related]
14. Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy. Humphreys EH, Hernandez LB, Rutherford GW. Cochrane Database Syst Rev; 2007 Oct 17; (4):CD006517. PubMed ID: 17943914 [Abstract] [Full Text] [Related]
15. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age. Penazzato M, Prendergast AJ, Muhe LM, Tindyebwa D, Abrams E. Cochrane Database Syst Rev; 2014 May 22; 2014(5):CD004772. PubMed ID: 24852077 [Abstract] [Full Text] [Related]
16. Stavudine or zidovudine in three-drug combination therapy for initial treatment of HIV infection in antiretroviral-naïve individuals. Spaulding A, Rutherford GW, Siegfried N. Cochrane Database Syst Rev; 2010 Aug 04; (8):CD008651. PubMed ID: 20687097 [Abstract] [Full Text] [Related]
17. A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I). Squires KE, Gulick R, Tebas P, Santana J, Mulanovich V, Clark R, Yangco B, Marlowe SI, Wright D, Cohen C, Cooley T, Mauney J, Uffelman K, Schoellkopf N, Grosso R, Stevens M. AIDS; 2000 Jul 28; 14(11):1591-600. PubMed ID: 10983646 [Abstract] [Full Text] [Related]
18. An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine. Foudraine NA, de Jong JJ, Jan Weverling G, van Benthem BH, Maas J, Keet IP, Jurriaans S, Roos MT, Vandermeulen K, de Wolf F, Lange JM. AIDS; 1998 Aug 20; 12(12):1513-9. PubMed ID: 9727573 [Abstract] [Full Text] [Related]
19. Lamivudine in combination with zidovudine, stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group Protocol 306 Investigators. Kuritzkes DR, Marschner I, Johnson VA, Bassett R, Eron JJ, Fischl MA, Murphy RL, Fife K, Maenza J, Rosandich ME, Bell D, Wood K, Sommadossi JP, Pettinelli C. AIDS; 1999 Apr 16; 13(6):685-94. PubMed ID: 10397563 [Abstract] [Full Text] [Related]
20. Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals. Spaulding A, Rutherford GW, Siegfried N. Cochrane Database Syst Rev; 2010 Oct 06; (10):CD008740. PubMed ID: 20927777 [Abstract] [Full Text] [Related] Page: [Next] [New Search]